Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Egypt J Immunol ; 25(1): 191-202, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30243011

RESUMEN

Chemerin and fetuin-A are recently discovered as metabolic regulator hormone in obesity and type 2 diabetes mellitus. However, elevated levels of chemerin and fetuin-A have been associated with insulin resistance and systemic inflammation. The present study aimed to investigate the significance of serum chemerin and fetuin-A levels in obese diabetic patients. Also, to determine whether, chemerin and fetuin-A along with markers of inflammation (IL6 and CRP) and obesity-related parameters in T2DM patients. Serum levels of chemerin and fetuin-A were evaluated using ELISA in 71 T2DM patients and 14 apparently healthy controls. Both groups were subdivided into obese and lean. Serum chemerin and fetuin-A levels were significantly higher in T2DM patients compared to controls (P < 0.001, for both) and significantly higher in obese T2DM in comparison to obese control group (P < 0.01 & P < 0.05, respectively). Serum chemerin and fetuin-A levels correlated positively with HbA1c, HOMA-IR, FBG, IL6 and CRP. In obese patients, serum chemerin and fetuin-A levels correlated positively with BMI and waist circumference. In conclusion, the strong association of chemerin and fetuin-A with insulin resistance and some inflammatory markers may provide an interesting link between obesity, inflammation and diabetes mellitus in human.


Asunto(s)
Quimiocinas/sangre , Diabetes Mellitus Tipo 2/sangre , Péptidos y Proteínas de Señalización Intercelular/sangre , Obesidad/sangre , alfa-2-Glicoproteína-HS/análisis , Proteína C-Reactiva/análisis , Humanos , Inflamación/sangre , Resistencia a la Insulina , Interleucina-6/sangre
2.
Environ Toxicol Pharmacol ; 39(2): 589-96, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25682005

RESUMEN

BACKGROUND: Egypt has one of the highest incidences of IUGR. The current study investigates the effect of heavy metals toxicity as risk factors of IUGR and determines the possible role of increased apoptosis in their pathogenesis. METHODS: This study was conducted in Assiut, Egypt, included 60 women diagnosed to have IUGR. We measured lead and cadmium levels in blood besides arsenic and cadmium levels in urine. Neonatal scalp hair sample were analyzed for arsenic content. Quantitative determination of human placental Bcl-2 and caspase-3 were performed. RESULTS: There are significantly higher levels of heavy metals and caspase-3 and lower levels of placental Bcl-2 in the IUGR group. The levels of heavy metals were positively correlated with caspase-3 while negatively correlated (except cadmium) with Bcl-2 levels. CONCLUSIONS: There is an alarming high level of heavy metals toxicity in Egypt that was positively correlated to IUGR. Increased placental apoptosis may be one of the possible mechanisms behind the effect.


Asunto(s)
Arsénico/toxicidad , Cadmio/toxicidad , Retardo del Crecimiento Fetal/epidemiología , Intoxicación por Metales Pesados , Plomo/toxicidad , Intoxicación/epidemiología , Adolescente , Adulto , Apoptosis , Arsénico/análisis , Arsénico/orina , Cadmio/sangre , Cadmio/orina , Estudios de Casos y Controles , Caspasa 3/metabolismo , Egipto/epidemiología , Femenino , Retardo del Crecimiento Fetal/sangre , Retardo del Crecimiento Fetal/metabolismo , Retardo del Crecimiento Fetal/orina , Cabello/química , Humanos , Plomo/sangre , Metales Pesados/sangre , Metales Pesados/metabolismo , Metales Pesados/orina , Placenta/metabolismo , Intoxicación/sangre , Intoxicación/metabolismo , Intoxicación/orina , Embarazo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Factores de Riesgo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...